Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2021

Dec 13, 2021

33039_dirs_2021-12-13_f890b712-a669-48b7-87e9-c701f29c36f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-12-09

Reporting Person: DeLuca Teresa (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-09 Common Stock P 5000 $4.00 Acquired 5000 Direct
2021-12-09 Common Stock P 2500 $3.98 Acquired 2500 Indirect
2021-12-09 Common Stock P 2500 $3.99 Acquired 2500 Indirect
2021-12-09 Common Stock P 2500 $3.95 Acquired 2500 Indirect

Footnotes

F1: Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.

F2: Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.